Biomea Fusion, Inc. Shares Authorized
Biomea Fusion, Inc. (BMEA) had Shares Authorized of 300.00 million shares as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesAuthorized · last filed 2026-08-05
- 2026-06-30: Common Stock, Shares Authorized 300.00M shares.
- 2026-03-31: Common Stock, Shares Authorized 300.00M shares.
- 2025-12-31: Common Stock, Shares Authorized 300.00M shares.
- 2025-09-30: Common Stock, Shares Authorized 300.00M shares.
| Period end | Common Stock, Shares Authorized | Common Stock, Shares Authorized as first filed |
|---|---|---|
| 2026-06-30 | 300.00M shares 10-Q · filed 2026-08-05 | |
| 2026-03-31 | 300.00M shares 10-Q · filed 2026-05-11 | |
| 2025-12-31 | 300.00M shares 10-Q · filed 2026-08-05 | |
| 2025-09-30 | 300.00M shares 10-Q · filed 2025-11-04 | |
| 2025-06-30 | 300.00M shares 10-Q · filed 2025-08-05 | |
| 2025-03-31 | 300.00M shares 10-Q · filed 2025-05-05 | |
| 2024-12-31 | 300.00M shares 10-K · filed 2026-03-24 | |
| 2024-09-30 | 300.00M shares 10-Q · filed 2024-10-29 | |
| 2024-06-30 | 300.00M shares 10-Q · filed 2024-07-31 | |
| 2024-03-31 | 300.00M shares 10-Q · filed 2024-05-02 | |
| 2023-12-31 | 300.00M shares 10-K · filed 2025-03-31 | |
| 2023-09-30 | 300.00M shares 10-Q · filed 2023-10-30 | |
| 2023-06-30 | 300.00M shares 10-Q · filed 2023-07-31 | |
| 2023-03-31 | 300.00M shares 10-Q · filed 2023-05-02 | |
| 2022-12-31 | 300.00M shares 10-K · filed 2024-03-28 | |
| 2022-09-30 | 300.00M shares 10-Q · filed 2022-11-07 | |
| 2022-06-30 | 300.00M shares 10-Q · filed 2022-08-01 | |
| 2022-03-31 | 300.00M shares 10-Q · filed 2022-05-16 | |
| 2021-12-31 | 300.00M shares 10-K · filed 2023-03-28 | |
| 2021-09-30 | 300.00M shares 10-Q · filed 2021-11-03 | |
| 2021-06-30 | 300.00M shares 10-Q · filed 2021-08-11 | |
| 2021-03-31 | 25.30M shares 10-Q · filed 2021-05-27 | |
| 2020-12-31 | 300.00M shares 10-Q · filed 2022-11-07 | 25.30M shares 10-Q · filed 2021-05-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B |